Ulrike Schatz

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany

Umidakhon Makhmudova, Ulrike Schatz, Nikolaos Perakakis et al. · Clinical Research in Cardiology · 2023 · 42 citations · Full text

Hyperlipidemia, Pharmacotherapy, Inclisiran Administration +19

Why an Apheresis Center Should Offer More Than One Lipoprotein Apheresis Method

Ulrich Julius, Sabine Fischer, Ulrike Schatz et al. · Therapeutic Apheresis and Dialysis · 2012 · 39 citations

Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study

Ulrike Schatz, S. Tselmin, Gabriele Müller et al. · Atherosclerosis Supplements · 2017 · 37 citations

Metabolic Syndrome, Cardiovascular Epidemiology, Health Policy +9

Effects of different lipoprotein apheresis methods on serum protein levels

Ulrich Julius, Gabriele Siegert, H. Kostka et al. · Atherosclerosis Supplements · 2015 · 35 citations

Biochemistry, Physiology, Immunology +7